Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $63.64 (+140.9%) * Over Last 12-Mos
Rating Score: 4.6 / 10   Percentile Rank: 49%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/20/2016 Deutsche Bank New Coverage Hold
(N/A)
30.00
(N/A)
27.10 26.42 -2.51% Details
8/17/2016 Morgan Stanley
» Updated 8/25/2016
Upgrade Overweight
(Equalweight)
42.00
(N/A)
26.60 26.42 -0.68% Details
Like VRX Ratings? Also take a look at WBA, AGN, PRGO, MNK

VRX Ratings News